C8ORF76 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.420400E-01
Normal-vs-Stage2
4.921400E-01
Normal-vs-Stage3
9.936200E-01
Normal-vs-Stage4
5.510000E-01
Stage1-vs-Stage2
8.328000E-01
Stage1-vs-Stage3
4.948000E-01
Stage1-vs-Stage4
9.752400E-01
Stage2-vs-Stage3
4.404600E-01
Stage2-vs-Stage4
8.966000E-01
Stage3-vs-Stage4
5.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.536400E-01
Normal-vs-AfricanAmerican
9.314400E-01
Normal-vs-Asian
3.550200E-01
Caucasian-vs-AfricanAmerican
2.514400E-01
Caucasian-vs-Asian
8.466600E-01
AfricanAmerican-vs-Asian
2.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.722600E-01
Normal-vs-Female
4.232200E-01
Male-vs-Female
5.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.811200E-01
Normal-vs-Age(41-60Yrs)
2.504200E-01
Normal-vs-Age(61-80Yrs)
5.781200E-01
Normal-vs-Age(81-100Yrs)
4.028200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.614600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.919000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.418800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.221600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.214800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.429600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.961400E-01
Normal-vs-Daily Drinker
3.839000E-01
Normal-vs-Weekly Drinker
5.205200E-01
Normal-vs-Occasional Drinker
1.351960E-01
Normal-vs-Social Drinker
5.444200E-01
Non Drinker-vs-Daily Drinker
3.429200E-01
Non Drinker-vs-Weekly Drinker
7.980000E-01
Non Drinker-vs-Occasional Drinker
3.820900E-03
Non Drinker-vs-Social Drinker
9.294000E-01
Daily Drinker-vs-Weekly Drinker
5.435400E-01
Daily Drinker-vs-Occasional Drinker
3.680300E-02
Daily Drinker-vs-Social Drinker
2.569800E-01
Weekly Drinker-vs-Occasional Drinker
1.751920E-02
Weekly Drinker-vs-Social Drinker
6.950800E-01
Occasional Drinker-vs-Social Drinker
6.337100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.933600E-01
Normal-vs-Grade 2
7.721600E-01
Normal-vs-Grade 3
7.029200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.197200E-01
Grade 1-vs-Grade 3
8.879200E-01
Grade 1-vs-Grade 4
4.933600E-01
Grade 2-vs-Grade 3
1.632980E-01
Grade 2-vs-Grade 4
7.721600E-01
Grade 3-vs-Grade 4
7.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.738000E-01
Normal-vs-NonDiabetic
3.934000E-01
Diabetic-vs-NonDiabetic
9.645200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.870400E-02
Normal-vs-NoPancreatitis
4.691800E-01
Pancreatitis-vs-NoPancreatitis
1.794750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.247800E-01
Normal-vs-N1
5.085400E-01
N0-vs-N1
1.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.870750E-01
Normal-vs-TP53-NonMutant
7.658800E-01
TP53-Mutant-vs-TP53-NonMutant
6.618000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
